Comparative correlation structure of colon cancer locus specific methylation: Characterisation of patient profiles and potential markers across 3 array-Based datasets

Journal of Cancer

Volumn 6, Issue 8, 2015, Pages 795-811

  Barat, Ana ^a   Ruskin, Heather J ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Biomarkers; Clustering; Colon cancer; Discriminant analysis; Epigenetic events; Multivariate data analysis; Mutation; Principal component analysis; Promoter hypermethylation; Screening

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; COLON CANCER; COMPARATIVE STUDY; DISCRIMINANT ANALYSIS; DNA METHYLATION; EPIGENETICS; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENETIC MARKER; GENETIC SELECTION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RECEIVER OPERATING CHARACTERISTIC;

EID: 84949667628     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.9883     Document Type: Article

References (31)

1. Kanthan R., Senger J.L., and Kanthan S.C. Fecal molecular markers for colo-rectal cancer screening. Gastroenterol Res. Pract. 2012; Epub.
2. Ogino S., Kawasaki T., Kirkner G.J, et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J. Mol. Diagn. 2007; 9: 305-314.
3. Shen L., Toyota M., Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. PNAS. 2007; 104(47).
4. Tanaka N., Huttenhower C., Nosho K., et al. Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. Amer. J. Pathol. 2010; 177(6): 2731-40.
5. Hinoue T., Weisenberger D.J., Lange C.P., et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 2012; 22(2): 271-82.
6. Karpinski P., Walter M., Szmida E, et al. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2013; 22(2):201-8.
7. Yagi K., Akagi K., Hayashi H, et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin. Cancer Res. 2010; 16: 21-33.
8. Barrett T., Wilhite S.E., Ledoux P, et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013; 41(Database issue): D991-5.
9. Barat A and Ruskin H.J. A Manually Curated Novel Knowledge Management System for Genetic and Epigenetic Molecular Determinants of Colon Cancer. The Open Colorectal Cancer J. 2010; 3:36-46.
10. Kibriya M.G., Raza M., Jasmine F, et al. A genome-wide DNA methylation study in colorectal carcinoma. BMC Med. Genomics. 2011; 4:50.
11. Kim Y.H., Lee H.C., Kim S.Y, et al. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epige-netic alterations. Ann. Surg. Oncol. 2011; 18(8):2338-47.
12. Partovi Nia V and Davison A. High-Dimensional Bayesian Clustering with Variable Selection: The R Package bclust. J. of Stat. Software. 2012; 47(5): 1-22.
13. Jombart T. adegenet: an R package for the multivariate analysis of genetic markers. Bioinformatics. 2008; 24:1403-1405.
14. Silviera M.L., Smith B.P, Powell J, and Sapienza C. Epigenetic differences in normal colon mucosa of cancer patients suggest altered dietary metabolic pathways. Cancer Prev. Res. (Phila). 2012; 5(3):374-84.
15. Pufulete M. Intake of dairy products and risk of colorectal neoplasia. Nutr. Res. Rev. 2008; 21(1):56-67.
16. Vargas A.J and Thompson P.A. Diet and nutrient factors in colorectal cancer risk. Nutr. Clin. Pract. 2012; 27(5):613-23.
17. Williams E.A. Folate, colorectal cancer and the involvement of DNA methylation. Proc. Nutr. Soc. 2012; 6:1-6.
18. Chen W-D, Han Z.J., Skoletsky J. et al. Detection in fecal DNA of colon cancer-specific methylation of the non-expressed vimentin gene. J. Natl. Cancer Inst. 2005; 97: 1124-32.
19. Itzkowitz S.H., Jandorf L., Brand R, et al. Improved fecal DNA test for colo-rectal cancer screening. Clin. Gastroenterol. Hepatol. 2007; 5(1):111-7.
20. Baek Y.H., Chang E., Kim Y.J, et al. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean pa-tients. Dis. Colon Rectum. 2009; 52(8):1452-1459.
21. Ned R.M., Melillo S., and Marrone M. Fecal DNA testing for Colorectal Cancer Screening: the ColoSure™ test. PLoS Curr. 2011; 3:RRN1220.
22. Shirahata A., Sakuraba K., Goto T, et al. Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients. Anticancer Res. 2010; 30(12):5015-8.
23. Zou H., Harrington J.J., Shire A.M, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol. Biomarkers Prev. 2007; 16(12): 2686-96.
24. Zou H., Allawi H., Cao X, et al. Quantification of methylated markers with a multiplex methylation-specific technology. Clin. Chem. 2012; 58(2): 375-83.
25. Glöckner S.C., Dhir M., Yi J.M, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009; 69(11): 4691-9.
26. Zhang J., Yang S., Xie Y, et al. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Cancer Epidemiol. 2011; 36(1):73-7.
27. Kisiel J.B., Yab T.C., Taylor W.R, et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer. 2012; 118(10):2623-31.
28. Hibi K., Goto T., Shirahata A, et al. Detection of TFPI2 methylation in the serum of gastric cancer patients. Anticancer Res. 2011; 31(11): 3835-8.
29. Arai E., Chiku S., Mori T, et al. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis. 2012; 33(8):1487-93.
30. Yamashita M., Toyota M., Suzuki H, et al. DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae. Cancer Sci. 2010;101(7):1708-16.
31. Lidgard G.P., Domanico M.J., Bruinsma J.J, et al. Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal Neoplasia. Clin. Gastroenterol. Hepatol. 2013; 11(10):1313-8.